High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer

Prog Clin Biol Res. 1994:389:487-95.

Authors

E A Stadtmauer¹, F S Hodi, C Sickles, D D Biggs, P Mangan, G Buzby, E Zaleta, L Silberstein

Affiliation

¹ Bone Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia.

PMID: 7535458

No abstract available

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Blood Cells / cytology
Blood Cells / drug effects
Breast Neoplasms / drug therapy*
Breast Neoplasms / secondary
Breast Neoplasms / therapy*
Carboplatin / administration & dosage
Cyclophosphamide / administration & dosage
Female
Granulocyte Colony-Stimulating Factor / pharmacology
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
Hematopoiesis
Hematopoietic Cell Growth Factors / pharmacology
Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cells / cytology
Hematopoietic Stem Cells / drug effects
Humans
Middle Aged
Thiotepa / administration & dosage
Time Factors
Transplantation, Autologous

Substances

Hematopoietic Cell Growth Factors
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Cyclophosphamide
Thiotepa
Carboplatin